Publicação: Benzofuroxan Derivatives as Potent Agents against Multidrug-Resistant Mycobacterium tuberculosis
dc.contributor.author | Fernandes, Guilherme F. S. [UNESP] | |
dc.contributor.author | Campos, Débora L. [UNESP] | |
dc.contributor.author | Da Silva, Isabel C. [UNESP] | |
dc.contributor.author | Prates, João L. B. [UNESP] | |
dc.contributor.author | Pavan, Aline R. [UNESP] | |
dc.contributor.author | Pavan, Fernando R. [UNESP] | |
dc.contributor.author | Dos Santos, Jean L. [UNESP] | |
dc.contributor.institution | Universidade Estadual Paulista (Unesp) | |
dc.date.accessioned | 2021-06-25T11:11:25Z | |
dc.date.available | 2021-06-25T11:11:25Z | |
dc.date.issued | 2021-04-20 | |
dc.description.abstract | Tuberculosis (TB) is currently the leading cause of death related to infectious diseases worldwide, as reported by the World Health Organization. Moreover, the increasing number of multidrug-resistant tuberculosis (MDR-TB) cases has alarmed health agencies, warranting extensive efforts to discover novel drugs that are effective and also safe. In this study, 23 new compounds were synthesized and evaluated in vitro against the drug-resistant strains of M. tuberculosis. The compound 6-((3-fluoro-4-thiomorpholinophenyl)carbamoyl)benzo[c][1,2,5]oxadiazole 1-N-oxide (5 b) was particularly remarkable in this regard as it demonstrated MIC90 values below 0.28 μM against all the MDR strains evaluated, thus suggesting that this compound might have a different mechanism of action. Benzofuroxans are an attractive new class of anti-TB agents, exemplified by compound 5 b, with excellent potency against the replicating and drug-resistant strains of M. tuberculosis. | en |
dc.description.affiliation | School of Pharmaceutical Sciences São Paulo State University (UNESP), Araraquara Jaú Highway KM 01 | |
dc.description.affiliation | Institute of Chemistry São Paulo State University (UNESP), Francisco Degni Street 55 | |
dc.description.affiliationUnesp | School of Pharmaceutical Sciences São Paulo State University (UNESP), Araraquara Jaú Highway KM 01 | |
dc.description.affiliationUnesp | Institute of Chemistry São Paulo State University (UNESP), Francisco Degni Street 55 | |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.description.sponsorshipId | FAPESP: 2016/09502-7 | |
dc.description.sponsorshipId | FAPESP: 2018/00163-0 | |
dc.description.sponsorshipId | FAPESP: 2018/11079-0 | |
dc.description.sponsorshipId | FAPESP: 2018/17739-2 | |
dc.description.sponsorshipId | FAPESP: 2018/21778-3 | |
dc.description.sponsorshipId | FAPESP: 2018/24783-8 | |
dc.description.sponsorshipId | CNPq: 404181/2019-8 | |
dc.description.sponsorshipId | CNPq: 429139/2018-7 | |
dc.format.extent | 1268-1282 | |
dc.identifier | http://dx.doi.org/10.1002/cmdc.202000899 | |
dc.identifier.citation | ChemMedChem, v. 16, n. 8, p. 1268-1282, 2021. | |
dc.identifier.doi | 10.1002/cmdc.202000899 | |
dc.identifier.issn | 1860-7187 | |
dc.identifier.issn | 1860-7179 | |
dc.identifier.scopus | 2-s2.0-85100702147 | |
dc.identifier.uri | http://hdl.handle.net/11449/208395 | |
dc.language.iso | eng | |
dc.relation.ispartof | ChemMedChem | |
dc.source | Scopus | |
dc.subject | antitubercular agents | |
dc.subject | benzofuroxan | |
dc.subject | multidrug-resistant TB | |
dc.subject | N-oxide | |
dc.subject | tuberculosis | |
dc.title | Benzofuroxan Derivatives as Potent Agents against Multidrug-Resistant Mycobacterium tuberculosis | en |
dc.type | Artigo | pt |
dspace.entity.type | Publication | |
relation.isDepartmentOfPublication | 5004bcab-94af-4939-b980-091ae9d0a19e | |
relation.isDepartmentOfPublication.latestForDiscovery | 5004bcab-94af-4939-b980-091ae9d0a19e | |
unesp.author.orcid | 0000-0002-7644-5466[1] | |
unesp.department | Ciências Biológicas - FCF | pt |